Next Generation Partners

Healthcare and life sciences in Israel

Arnon, Tadmor-Levy

In 2022, Yigal Arnon merged with Tadmor Levy to form Arnon, Tadmor-Levy. The ’very talented’ life sciences team has extensive experience of advising Israel’s largest chain of private hospitals and global pharmaceutical companies on regulatory and governance as well as commercial and transactional issues. The firm has ‘unique expertise’ in serving as the internal legal counsel for institutional ethics committees for the secondary use of health data. Barry Levenfeld is an expert in IP transactions and licensing within the life sciences industry, and Daniel Green handles complex commercial transactions and joint venture agreements. The ‘wise and cleverEfrat Shapira-Orren specialises in healthcare law and regulation.

Other key lawyers:

Barry Levenfeld; Daniel Green; Efrat Shapira-Orren; Yoheved Novogroder Shoshan; Avi Farchi; Avital Bruker-Yamin; Miriam Friedmann; Arthur Gorelik


Testimonials

‘A very talented team, with a very unique expertise in the healthcare market and the entire healthcare-related legal practice. They provide full scale coverage of legal consulting on the entire activity of our group of hospitals and medical centers, providing high quality and very professional service. The healthcare team is supported by the firm’s other departments when their expertise is needed, securing high quality and professional treatment of all legal issues.’

‘Efrat Shapira-Orren is extremely unique in her breadth of knowledge and depth of understanding of the Healthcare market. She is an integral part of the group’s management and covers the full spectrum of our business. I consider her as a standout brilliant lawyer, a real healthcare expert, with analytic thinking, high creativity, deep business and economic understanding and very high managerial capabilities. Her knowledge, legal and business capabilities, creativity and understanding of the entire healthcare market stand out also when compared to other external or internal lawyers in the healthcare field.’

‘I’ve been working with Efrat Shapira-Orren and her team for many years and I’m still impressed by their professionalism curiosity and capabilities. I find that the team is an asset in reaching agreements in a timely manner, helping to clarify the various aspects involved in the collaboration.’

‘I find the team diverse with an everlasting attempt to find creative solutions to unique challenges.’

‘Efrat Shapira-Orren is an exceptional person, both as a colleague and as an extremely knowledgeable and effective lawyer. She is very well versed in all aspects of hospital life, regulation, business risk management and governance. All this while managing to be pleasant and effective as the authority in all legal matters.’

‘We work regularly with Avi Farchi. During our joint work I discovered a sharp person who understood our problems quickly and describe us our possibilities Although I know Avi handles many cases, he always gives the feeling that he is available for me and his goal is to find the best solution for me.’

‘What makes this practice unique is their team work and how they always have the right person for each question. I always feel like I’m working with a team versus working with a one-man show and hoping their knowledge is enough. It’s their synergy of minds, experiences, knowledge and capabilities that I love and trust!’

‘The company in general and Efrat in particular are super professional, effective, striving all the time to achieve quality and excellence.’

Key clients

Assuta Medical Centers Ltd. and all subsidiaries


Assuta Ashdod Ltd.


Incentive Incubator Ltd.


SAREL Supplies & Services for Medicine Ltd.


Sinusafe Medical Ltd.


Allergan Plc


Stryker Corporation


Super Spectra


Alpha Bio Tec. Ltd.


Endomatic Ltd.


Medison Pharma Group


Heracure Medical


Bio Refine Ltd.


Bioventus LLC


Human Xtensions


Barclays Capital (LON: BARC)


Pocared Diagnostics Ltd.


Teva Pharmaceutical Industries Ltd.


Oculis SA


FutuRx


MEDX XELERATOR


ALYN Hospital


Atox Bio


Enlivex Therapeutics Ltd. (TASE: ENLV) (NYSE: ENLV)


Sirvir Ltd.


Prilenia Therapeutics


Hubei Forbon Technology Co., Ltd.


Alma Lasers Ltd.


Integra Holdings


Simplificare, Inc.(‘Simplee’)


Premia Spine


RMDY Health


On-Sight Medical


Genmab A/S (CPH: GMAB)


Bio-Change


BioLineRx Ltd. (NASDAQ: BLRX) (TLV: BLRX)


Work highlights


  • Represented the Assuta network of nine private hospitals on several significant matters in the healthcare sector, including an international tender, regulatory affairs, clinical trials and research collaborations, strategic commercial agreements and the development of innovative digital projects.
  • Represented Boston Scientific Corporation in the acquisition of the laser surgery division of Lumenis, including its subsidiaries and manufacturing facility in Israel.
  • Represented Altaris Capital Partners, the buyer, in its acquisition of the prescription pharmaceuticals business of Perrigo Company Plc (PRGO) which is traded on both the New York and Tel Aviv Stock Exchanges.

FISCHER (FBC & Co.)

FISCHER (FBC & Co.)’s healthcare and life sciences team has extensive expertise in advising international and Israeli companies in complex litigation proceedings and commercial transactions. The group has considerable strength in medical device-related class actions, representing global entities, as well as providing routine guidance to businesses regarding regulatory compliance issues. Raz Tepper assists multinational and local players across the biotechnology, genomics, and healthcare service industries, and Eran Yaniv specialises in cross-border transactions with an emphasis on life sciences. Shmulik Fried and Tal Wiesengrun are other key names. Senior associate Warren Wienburg provides additional support.

Practice head(s):

Raz Tepper; Eran Yaniv


Other key lawyers:

Shmulik Fried; Tal Wiesengrun; Warren Wienburg


Testimonials

‘Tal Wiesengrun has the perfect combination between professionalism and humaneness, without compromising on assertiveness. It is a pleasure to work with her.’

‘Kind and professional, with high experience in the field we needed (class actions).’

Key clients

Perrigo


Kamada Ltd.


Novartis (Sandoz AG, a Novartis division)


Viola


Bristol-Meyers Squibb Company


Purple Biotech


CytoReason


Metasight Diagnostics


OrbiMed Healthcare Fund


Rainbow Medical Ltd.


Abbott – St. Jude Medical


Hadassah Medical Organisation


Prof. Sarah Ferber (a professor at Sheba Hospital)


Leumi Partners


Allied Group


Elgan Pharma


Tarom Innovative Technologies Ltd


Starget Pharma


Adicet Bio Ltd.


Medici Medical LDT


Lapidot Medical Import & Marketing LTD


Allium Medical


Alpha-Bio Tech Ltd.


American Well Corporation


Meuhedet Health Fund


Check Cap Ltd.


MetaboMed Ltd.


Motus G.I.


NanoSpun Technologies


Nano Retina Ltd.


Nutrinia


Octopus Ventures


Pangea Therapeutics Ltd.


Pythagoras Medical Ltd.


Real Imaging Holdings Ltd.


Work highlights


  • Represented Perrigo, a Dublin-based over-the-counter drug manufacturer and its Israeli subsidiaries, on an ongoing basis with respect to its legal matters in Israel, including commercial and litigation matters.
  • Represented Purple Biotech in all of its legal needs, including corporate governance, securities law issues (both in Israel and the US), commercial agreements, distribution agreements, strategic cooperation and alliances as well as litigation matters.
  • Represented Hadassah Medical Organization, the operator of Hadassah Ein-Kerem and Hadassah Mount Scopus hospitals, in a broad range of issues, including regulation of the Israeli health system, involving regulatory issues and regarding Bone Marrow Registry in proceedings before the Military Attorney General.

Goldfarb Gross Seligman & Co.

Goldfarb Gross Seligman & Co. has extensive expertise in handling major international M&A transactions in the Israeli healthcare, biotech, pharmaceutical, medical devices, medical cannabis and life sciences sector, as well as assisting companies with contentious regulatory issues. The firm also represents senior doctors before disciplinary committees and in criminal investigations, whilst offering specialised legal expertise to healthcare entities and organizations. Roy Lieber handles the M&A and corporate investment elements. Hili Cohen brings expertise in assisting technology-based life science companies with commercial transactions and licensing agreements, while Tami Fishman Jutkowitz regularly counsels international and domestic clients on private financing and strategic alliances. The firm was formed in January 2023 following the merger of Goldfarb Seligman and Gross & Co, both of which housed prominent practices.

Practice head(s):

Hili Cohen; Ashok J. Chandrasekhar; Ayal Shenhav; Richard Mann; Zvi Bar-Nathan


Other key lawyers:

Roy Lieber; Tami Fishman Jutkowitz; Danny Kleinhendler; Shir Shalev; Ofir Goldstein


Testimonials

‘Dedicated team; high availability; excellent response times. Knowledge in medical devices commercial agreements.’

‘Hili Cohen is our partner – she is a professional in corporate and commercial for a growing company with international businesses (US and Europe); She brings professional advice and excellent solutions for our private fund-raising processes.’

‘The firm took the time to get to know our business, our key players and made sure to adjust their services to our needs. Their collaboration with us is truly exceptional. They are able to juggle a variety of legal matters and provide us with responses in a timely manner by connecting us with their partners/associates in the relevant field.’

‘They showed the ability to understand the main legal risks while still enabling flexibility to the business. Very solution-oriented.’

‘They are friendly and great at creating a real rapport with us as clients. No matter how late it was in the day, I knew they would make themselves available for any urgent matter. They both felt like real partners to our team.’

‘I was surprised to find out that Ofir Goldstein was such a young associate as his legal advice greatly surpassed the experience I would expect at his level. He is pragmatic, creative and showed great interest in understanding the business and our technology.’

Key clients

Sonova Holding AG


The Board of Directors of Clalit


Cardiovalve Ltd.


BrainsGate Ltd.


EarlySense Ltd.


Ohhmed Medical Ltd.


ReWalk Robotics Ltd.


‘Lilach- Live and Die with Dignity’


The Israeli Medical Association


Magen David Adom In Israel (MDA)


Maccabi Healthcare Services


Carestream Health, Inc.


AquafitIntimate Ltd.


National Insurance Institute of Israel


Rafa Laboratories Co. Ltd.


Itamar Medical Ltd.


Wize Pharma Ltd.


Breath of Life International Ltd. (BOL Group)


Menorah Insurance Company Ltd.


Temi Global Ltd.


RealView Imaging Ltd.


Enzymit Inc.


Synergio (Y&B Mother’s Choice Ltd.)


VitalGo Systems


SHL Telemedicine Ltd.


3 Millenium Group


Accelmed


Acthera Therapeutics Ltd.


AISAP


AIVF


Align Technology, LTD


Almeda Ventures Limited Partnership


American Well


ARDiS Ltd.


Arkin Holdings


Atricure


BactoByte


Best Brain


BeyondMeat


Bioforum


BiondVax


BionTech


Biotest AG


BioMeat FoodTech


Brainsway


Biogen


Bunge


Cannopiea


CLAL Biotech INDUSTRIES LTD


ClearSkin Ltd.


Collplant


Cookin


Covington & Burling


Cronos Group


Deloitte


Curatio Healthcare


Edwards Lifesciences Corporation


eHealth Ventures


Elanco


Elnis Beauty Ltd


Endospan


Enveric Biosciences, Inc.


Eximo Medical Ltd.


GI View Ltd.


Hogan Lovells


Heally Israel LTD.


Human Xtensions Ltd


Igentify Ltd.


Industrie Biomediche Insubri SA


InMed


InnoBev Ltd.


InnovaHealth Partners


Inovytec Medical Solutions


Insightech


Intratech Medical


Invisicare


Invitae


Izun Pharma


Keystone Dental Inc.


KTR Medical


LifeVantage


Madrigal Pharmaceuticals


Magenta Medical Ltd.


Mazor Medical Ltd.


MDGO Ltd.


MDI Health Technologies.


MDigo


MedCPU


MediMe.


Medtronic


Milagro


Morrison & Foerester


Mother’s Choice


MSD


My Ukko


NeuroSense Therapeutics


Nailomatic Ltd


Novolog group


opticaldiagnostics.com


Orasis


Organigram


Ortho Clinical Diagnostics


Osborne Clark


Outburn Ltd.


Petsapien.


Pharmaceutical Research Associates (PRA)


PRA HealthScience.


Premier Research


Providence Health & Services


Pulsemore


Q-Art Ltd.


Rainbow Medical Ltd


Rapid Medical Ltd


Redhill Biopharma Ltd


Respiration Scan


Regeneron pharmaceuticals inc


Rimonim


Roche Pharmaceuticals (Israel) Ltd.


SciVac


SeeGene


SheRun Labs Ltd.


Sherman Lab


Sol-Gel Technologies Ltd


Sonivie Ltd


Spatz FGIA


Sufresca


Telesofia Medical Ltd


Therapix Biosciences Ltd


Under Pressure


Valcare Medical


Vertex Pharmaceuticals Inc


Vibrant Ltd


VRHealth


Well Beat


WellBeat Ltd


West Pharmaceutical Services, Inc.


Yissum Research Development


Work highlights


  • Representing Ohhmed Medical Ltd. throughout all stages of development of its medical device Vertica®, including co-development agreements with hospitals in Israel, clinical research agreements, investment agreements and more.
  • Representing Itamar Medical in its acquisition by ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and provides related software solutions, for approximately US$538 million.
  • Representing the Israeli Medical Association, the professional association of physicians in Israel, in a wide range of matters, including regulation, litigation, employment and more.

Herzog Fox & Neeman

Herzog Fox & Neeman’s ‘super professional’ team has vast experience of representing major Israeli Health Funds and international pharmaceutical and insurance companies, providing comprehensive regulatory and commercial advice. The department routinely assists hospitals in their collaborations with startups and national research institutes regarding health data for the development of health-related technologies and AI. Of counsel Zohar Yahalom has 25 years’ experience in the healthcare field and is highly knowledgeable on all regulatory developments within the sector. Neta Dorfman-Raviv has expertise in advising governmental authorities and multinational entities on regulations and commercial matters, and the ‘super intelligent’ Dan Sharot acts for venture investors in healthcare companies and handles all IP aspects of life sciences-related M&A.

Practice head(s):

Neta Dorfman-Raviv; Zohar Yahalom


Other key lawyers:

Dan Sharot


Testimonials

‘They have a strong team on every matter related to the biotech industry for company creation, dealmaking. Provide service in timely manner, at top level with a one-stop-shop.’

‘Dan Sharot is a humble, confident professional who listens well and has strong capability of differentiating between what matters – and what doesn’t – and focusing on what matters for the business. This is rare for a top lawyer in this field.’

‘Focus on the company, willingness to support any activity needed and at times that are needed. In addition, the work is done with a personal touch and with respect to the company standpoint, strategy and goals.’

‘Dan Sharot, the partner we work with in the last more than ten years is a SUPER intelligent, educated, professional lawyer. Dan is very responsive and available. I can state that Dan has significantly contributed to the commercial success of my company!’

‘Have been working with HFN for about 4 years, developed a great relationship. The team is very professional and gained our full trust. The team was available on urgent matters around the clock, and always gives timely feedback and is very professional.’

‘I have been working with Dan Sharot. Dan is a hardworking individual and provided us with the best support on routine practice, as well as complicated situations. Dan become a go to person with a lot of trust from any legal issues we encounter.’

‘The HFN Healthcare and life science practice is a business-minded, capable and creative team that is practicable, efficient and knowledgeable holding standards that are comparable to any top big international law firm. They know the global industry’s ins and outs along with an in-depth understanding of the Israeli aspects in a way that is exceptional for an Israeli law firm.’

‘Their efficient, experienced, responsive and professional team makes working with them a pleasure and comparable to any international big law firm.’

Key clients

Accenture


Adama


AION Innovations Labs


Alpha Omega


Assuta Ashdod


Assuta Medical Centers


Clal Insurance Company


DeePathology


Johnson & Johnson


Liveperson


Phoenix Insurance Company


Fundbox


Maccabi Health Services (HMO)


Madanes Insurance Agency


Magen David Adom


Medisafe


Meuhedet (HMO)


Novolog


Merck Serono


Naturapil


Eli Lilly Israel


GE HealthCare


Abbvie


Philips Healthcare


Sahara Medic


Steba Biotech


Boehringer Ingelheim Israel


Teva


Wolt


Zimmer Biomet


Work highlights


  • Acted as a General Counsel for Magen David Adom, Israel’s National Emergency Services Association and the representative to the international Red Cross, as well as General Counsel to its assembly and to its executive committee (equivalent to board of directors).
  • Advised Pfizer, Merck KGaA, Teva, and AstraZeneca together with AWS/Amazon in the establishment of AION Innovation labs, an innovation lab in Israel for start-ups in the field of AI applications for drug discovery and computational biology.
  • Provides ongoing regulatory and commercial and regulatory advice to Meuhedet with respect to health insurance coverages it provides its members as an insurer, and to its employees, doctors and officer as a policyholder and in respect of pharmaceutical regulation and clinical trial agreements.

Horn & Co

Horn & Co’s team has ‘extensive knowledge’ of life sciences matters, advising clients on all aspects of transactions, the licensing of intellectual property and agreements with governmental authorities and academic institutions. The firm has unique expertise in innovative and growing areas of healthcare, including cryptocurrency-related activities and biotech affairs. Yuval Horn is a ‘standout’ lawyer, regularly assisting companies in international transactions and acquisitions regarding the life science sector, and Keren Kanir has expertise in commercial issues relating to IP and venture capital funds.

Practice head(s):

Yuval Horn


Other key lawyers:

Keren Kanir; Yonatan Levinstein; Uri Dotan; Shimrit Roznek


Testimonials

‘Horn’s team is one of the most professional I have worked with. In addition to the fact that they are always available for any question, they have very extensive knowledge in the field of high-tech and specifically in the field of healthcare. They have helped us many times in solving complex problems and innovative issues and we really enjoy working with them and know that we can trust them with any question’

‘The team at Horn is always available, always makes us feel like we are their only clients, and treats every legal issue thoroughly and seriously. I would like to praise Keren Kanir, Yuval Horn and Yonatan Levinstein who are very smart, always available and always willing to help with any issue.’

‘A real boutique law firm with the highest degree of professionalism on VC transactions, start-up transactions, financing, M&A, IP, licensing, restructuring, etc. Very broad overview and network within the relevant industries, especially biotech.’

Key clients

Nanox AI


Vascular Biogenics Ltd.


Cellect Biotechnology Ltd.


Protalix BioTherapeutics, Inc., and Protalix Ltd.


Nanosynex Ltd.


Rocket Life Ltd.


Scopio Labs Ltd.


Diagnostic Robotics


Pontifax VC


Work highlights


  • Represented Scopio Labs Ltd. in negotiations for a worldwide partnership with Beckman Coulter Inc. pursuant to which Beckman is to market and distribute Scopio’s next generation peripheral blood smear platforms in hematology laboratories around the world.
  • Represented Diagnostic Robotics in a $30M fundraising round and conversion of a $15M advance investment agreement.
  • Advised our client when entering into a financing agreement with Qualigen Therapeutics Inc, under which Qualigen invested $ 600,000 in consideration for shares of Nanosynex and committed to a financing of $10.4 million subject to achievement of certain performance milestones by NanoSynex.

Lipa Meir & Co

Lipa Meir & Co’s ‘wonderful and passionate’ life sciences team has specialist expertise in advising domestic and international companies within the cannabis and public and private healthcare sectors. The firm regularly assists global pharmaceutical and hi-tech corporations - including Pfizer and Medtronic - with matters ranging from licensing agreements to complex M&A. Gary Copelovitz, who is a ‘star in life sciences law’, specialises in offering strategic legal and regulatory advice to Health Maintenance Organisations, and Meir Elbaum has experience of aiding hospitals and private clinics in preparing tenders and agreements. Associate Amit Zomer-Fedida focuses on strategic investments and cross-border M&A.

Practice head(s):

Gary Copelovitz


Other key lawyers:

Meir Elbaum; Amit Zomer-Fedida


Testimonials

‘Clients will find Lipa Meir’s healthcare and life sciences practice wonderful to work with. Their extensive knowledge of the field is always combined with a passionate search for practical solutions that actually help businesses.’

‘Gary Copelovitz is a star in life sciences law and absolutely my go-to person in Israel. I always appreciated his personal, yet learned, approach and always knew I was in good hands.’

Key clients

Galil Okek Incubator


OPTM.RX Ltd.


Exosomm Ltd.


Intelis Industries Ltd.


Biopharma Credit PLC


Clalit Health Services


Lahav CRO


L.E.M. Laboratory for Early Detection Ltd.


Laser Team Medical Ltd.


Mor Institute for Medical Data Ltd.


Mor-Mar Ltd.


Tel Hashomer Hospital


Shila Medical Services Ltd.


Mor Research Applications Ltd.


Medtechnica Orthophone Ltd.


Natural Birth Center


Tel Bar Industries For Health Institutions Ltd.


Clalit Biomedical Engineering Ltd.


Mileutis Ltd.


Shekel Brainweigh Ltd.


Dikla Insurance Company Ltd.


Harel Insurance Company Ltd.


Work highlights


  • Acted for the Galilee Ofek Incubator, with a record of successful investments in start-up companies in the fields of healthcare and life sciences, in relation to setting up corporate vehicles to leverage medical technology and innovation.
  • Advised Mileutis Ltd., a clinical-stage biopharmaceutical company, on a raft of issues, including an agreement to finance the registration and commercialisation of Mileutis’ drugs in the US and Europe.
  • Acted for Clalit Health Services, inter alia, in joint ventures for the establishment of biobanks, to name but a few: (a) one JV with BC Platforms, a Swiss-US conglomerate; (b) another with the State of Israel, in its national initiative known as “Psifas” – a national data infrastructure for research in genetics and medical data.

M. Firon & Co Advocates and Notaries

M. Firon & Co Advocates and Notaries’s healthcare team has a stellar reputation acting for major players in the pharmaceutical industry as well as medical centres on cross-border transactions and regulatory issues. The department also has extensive experience of representing startup companies in the healthcare sector, aiding these entities with licensing agreements and investment rounds. Baruch Shugol and Sivan Narkiss co-head the team, with the former bringing expertise in all commercial aspects required for the operations of pharmaceutical companies, and the latter a popular choice for multinational pharmaceutical companies, distributors and medical startups.

Practice head(s):

Baruch Shugol; Sivan Narkiss


Other key lawyers:

Jacob Enoch


Testimonials

‘Robust, ultra professional, lightening quick, absolutely first class.’

‘Baruch Shogul – a super star who has seen it all. Sivan Narkiss – up and coming. Jacob Enoch – our main contact. As brilliant as they come. Very knowledgeable on healthcare law.’

‘Wide experience in fundraising, complex agreements, and international engagements, as well as day-to-day operations. Excellent availability.’

‘Baruch Shogul – #1. Full stop. As simple as that. Sivan Narkiss – very very good. Jacob Enoch – As brilliant at this capacity as in his many others.’

‘Firon supports both our transactional work and our commercial work (mainly licensing and JVs) both in Israel and abroad as well as our regulatory needs.’

‘Jacob Enoch – words can’t describe our satisfaction. He is an essential member of our strategic team. He understands our business, our software, finance, strategy, and of course the law.

‘Baruch Shogul and Sivan Narkiss – the best healthcare team in the country as mentioned above. Baruch is an industry veteran you absolutely need in your corner.’

Key clients

Gilead


Tel Aviv Sourasky Medical Centre


Clalit Health Services


Pharma Israel


Sanofi


EMMS Nazareth Hospital


Hadassah Medical


Herzliya Medical Centre


S.L.H. Medical Services Ltd.


Guangzhou Sino-Israel Bio-industry Venture Capital Investment Fund


CorNeat Vision


DMC


Geffen Medical


Novolog


Work highlights


  • Represented EMMS Nazareth Hospital regarding various aspects of its operation.
  • Represented Herzliya Medical centre regarding various aspects of its operation.
  • Representing the global pharma company Sanofi.

S. Horowitz & Co

S. Horowitz & Co combines expertise in litigation and regulatory issues with transactional knowledge, focusing on all aspects of the commercialisation of patents and assisting with M&A. The life sciences department represents clients across the industry, including innovative and generic pharmaceutical companies, healthcare startups and research organisations. Tal Band acts for local and foreign entities within the pharmaceutical field in complex litigation relating to patents and trade marks, and Dovev Apel is an expert in all regulatory aspects pertaining to medical devices, food supplements and e-health technology. Yair Ziv is also noted.

Practice head(s):

Tal Band; Dovev Apel


Other key lawyers:

Asaf Renrsler; Moran Katz; Yair Ziv


Testimonials

‘Very professional, practical and business oriented. They provide thorough legal advice.’

‘Dovev Apel, a very experienced regulatory and IP counsel, has the ability to understand the flexibility needs of the business, understanding the client’s risk tolerance policies and focusing on the main issues.’

Key clients

Teva Pharmaceutical Industries Ltd.


Sanofi S.A.


Masimo


Clever Leaves Holdings, Inc.


Sun Pharmaceutical Industries Ltd.


Taro Pharmaceutical Industries Ltd.


The Chemical, Pharmaceutical and Environmental Society of the Manufacturer’s Association of Israel


Maccabi Healthcare Services


Procter & Gamble Israel Ltd.


Dexcel Ltd. and Dexcel Pharma Technologies Ltd.


Novocure Inc.


Hadassah Medical Organization


Allergan Inc.


Aleph Farm Ltd.


Indena S.p.A.


Forever Living Products (Israel) Ltd.


Seegnal e-health Ltd


Genmab A/S


Medial Group


Santhera Pharmaceuticals


Yeda Research and Development Limited


Oxygnium


I.S.R – The Institute for Skin Research


Zimmer Biomet


Takeda Pharmaceutical Company


Sanofi Aventis


Galmed International Ltd.


Hadasit Medical Research Services and Development Ltd.


Advanced Oncotherapy plc.


Solomon, Levine, and Elstein Ltd.


Simplivia Healthcare ltd.


Tel Aviv University


M.I.P Veterinary ltd.


Euromar Ltd.


Amgen Inc.


Rhenium research laboratory equipment Ltd.


Alpa Cosmetics


K.I. Research Institute (R.A.)


Work highlights


  • Acting for Teva Pharmaceutical Industries Ltd. on all its contentious and regulatory work in Israel, as well as a series of commercial transactions.
  • Representing Sanofi Aventis SA in a highly complex motion for certification of a $4,500,000 class action suit.
  • Representing Taro Pharmaceutical Industries Ltd. in a motion for certification of a class action regarding information leaflets on potential risks related to the use of opioids.

Agmon with Tulchinsky Law Firm

In December 2022, Agmon & Co. Rosenberg Hacohen & Co. merged with Tulchinsky Marciano Cohen Levitski & Co. to form Agmon with Tulchinsky Law Firm. The group has extensive experience of acting for major venture capital players and smaller corporations, providing tailored advice on matters ranging from litigation to M&A transactions to medical device companies and healthcare funds. David Cohen regularly represents entities in private financing rounds and distribution agreements, and Uriel Barak brings expertise in international commercial law proceedings. Alon Tabak-Aviram specialises in technology licensing and development, and Osnat Sarusi-Firstater regularly acts for entrepreneurs and investors.

Practice head(s):

David Cohen; Uri Barak


Other key lawyers:

Alon Tabak-Aviram; Gershon Shalom-Winter; Tamar Nesher; Osnat Sarusi-Firstater


Key clients

Teva Pharmaceutical Industries Ltd.


Minovia


Neuroderm


The National Institute for Biotechnology in the Negev


Ziv Health care


CH-Health


RedHill Biopharma Ltd.


ConTIPI Medical Ltd.


Luneau Technology


Haldor


Biond Biologics


RA Capital


Widex


Work highlights


  • Acted for RedDress Ltd., a medical device company, in a range of activities, including a significant investment in May 2022.
  • Act for National Institute for Biotechnology in the Negev, LTD. (NIBN), a unique research institute located within Ben-Gurion University (BGU), in their licensing, joint ventures, and collaboration activities in Israel and abroad.
  • Represented Luneau Technology in its acquisition of a California-based company – Optovue Inc. via a reverse-triangular merger.

Amit, Pollak, Matalon & Co. Advocates and Notary

Amit, Pollak, Matalon & Co. Advocates and Notary’s life sciences department specialises in assisting companies in the medical cannabis industry, as well as covering all IP and regulatory matters arising within the pharmaceutical sector. The firm’s client base includes international and domestic names, notably an Israeli medical devices company and a German chemical nanotechnology company. Ian Rostowsky has expertise in M&A transactions and investments involving healthcare entities, and Yoav Etzyon regularly advises startups and potential investors. Omer Carmel is also noted as key.

Practice head(s):

Ian Rostowsky; Yoav Etzyon


Other key lawyers:

Omer Carmel; Stephen Barak Rozen; Chagit Pedael; Assaf Baruch


Testimonials

‘The team includes lawyers who have vast experience in investment rounds, IPOs, Company’s files, documents required for investors, Directors rolls and activities etc. They are very responsive and meet time frames as needed.’

‘The prime contact point leads the team and bring the experience to manage his team knowing the expertise of each individual who support him on different area in accordance with the level of work and the appropriate costing.’

Key clients

Novartis


Allergan


BT Beamedical Technologies


CanNegev Ltd.


F.O.R.E Biotherapeutics Ltd.


Galmed Pharmaceuticals Ltd.


Good Energies Ltd. Also known as B Cure Laser


Healeon Medical Ltd.


Ilumigyn Ltd.


IM Cannabis Corp


KeepMed Ltd.


LionBird L.P


Nano-X Imaging Ltd.


New Pace Ltd.


Orsense Ltd.


Polypid Ltd.


Red C Biotech Ltd.


Work highlights


  • Represented Nano-X in its up-to US$194 million acquisition of Israeli start-up Zebra Medical Vision Ltd., a deep-learning medical imaging analytics company.
  • Advise Illumigyn, a medical technology company, on its commercial agreements, recently including a deal worth hundreds of millions of dollars with Peramare Enterprises Ltd. and Afreximbank to deploy its gynecological imaging system and platform throughout Africa.
  • Advise Allergan on intellectual property issues, mainly on trademark matters, such as use of trade names, and confidentiality issues.

Barnea Jaffa Lande & Co.

The ’highly knowledgeable’ team at Barnea Jaffa Lande & Co. represents a client base of prominent local and international pharmaceutical, biotechnology, and medical device companies. The group demonstrates strength in corporate transactions and M&A activity, along with expertise in IP rights and raising capital in the life sciences field. Practice head Michael Barnea has vast experience of providing strategic counsel to boards of biotechnology and pharmaceutical companies, and Ken Shaked has forged a reputation for developing IP strategies for startups.

Practice head(s):

Michael Barnea


Other key lawyers:

Ken Shaked; Ariella Dreyfuss; Ido Freund


Testimonials

‘I find them true specialists in life sciences and healthcare. They are easy to deal with, pragmatic, and provide excellent client service. They are up-to-date with the local and relevant regulations and bring us a real added value.’

‘I work with a great team of lawyers – The team is highly knowledgeable about the life sciences sector. Micky Barnea supervises all.’

Key clients

Johnson & Johnson Development Corporation


CardiacSense


BioGenCell


Manor Medical Group


Maccabi Healthcare


The Enaim Group


Marpe Technologies


Tuttnauer


Symbiosis C.M.


Danel Group


Work highlights


  • Represent Johnson & Johnson Development Corporation (JJDC), the venture capital fund of Johnson & Johnson, the largest pharma company in the world, in its USD hundreds of millions investments in Israeli medical and biotechnology companies.
  • Represented CardiacSense, the developer of an all-in-one medical watch, since its establishment.
  • Advised BioGenCell- a stem cell research and development company located at Laniado Hospital.

Gornitzky & Co.

Gornitzky & Co.‘s ‘strong and responsive’ pharma and healthcare team provides advice in relation to agreements with the state of Israel, in tenders of Israeli Health Organisations, and in various regulatory proceedings. The firm has an extensive roster of life sciences clients, notably companies that use or are developing digital health tools and telehealth services. Assaf Harel is ‘very knowledgeable’, specialising in regulatory and compliance matters, and Itamar Mei-Zahav consistently represents companies in cross-border corporate transactions. Netta Shaked-Stadler assists hi-tech companies, and Shy Baranov routinely assists with international M&A in the field.

Practice head(s):

Assaf Harel; Itamar Mei-Zahav; Netta Shaked-Stadler; Shy Baranov


Other key lawyers:

Ohad Gurfinkel; Rebecca Genis


Testimonials

‘The team is highly experienced in the field with unique capabilities (corporate, commercial, privacy etc.).’

‘Assaf Harel is highly knowledgeable and provides excellent service (high quality and timely service).’

‘Strong and responsive team, experienced representing both investors and start-up tech companies.’

‘Itamar is very knowledgeable on a wide-range of issues and can tap into a wealth of experience to drive optimal deal terms and market conditions.’

Key clients

Abbott Laboratories


Siemens Healthcare Ltd.


Moderna


Venus Concept Ltd.


V-Wave Ltd.


Curatio.DL Ltd. (a subsidiary of FBF IP Group)


Biomx Inc.


Fluidfile Ltd.


PlanetArc Bio Ltd.


Trichome Financial Corp.


Allergan Aesthetics


Qure Ventures


Clal Insurance Company Ltd. and its affiliates


Piper Sandler, Cowen and Company and SVB Leerink


Cantor Fitzgerald


Microport NeuroTech International Limited


Nevo Medical Ltd.


Our Crowd


ILEX Medical Ltd.


Zoll Medical Corporation


IdentifAI Genetics Ltd.


Augmedics Inc.


Physimax Technologies Ltd.


Levation Pharma Ltd.


Eitan Medical


CELLECT BIOTHERAPEUTICS LTD.


Baibys Fertility Ltd.


Polypid Ltd.


Makesense Ltd.


Work highlights


  • Represented Zoll Medical Corporation, vis-à-vis the ICA regarding a USD 560 million merger of its subsidiary with Itamar Medical Ltd, an Israeli medical device company focused on sleep apnoea diagnosis.
  • Represented V-Wave Ltd. in its Series C financing round of USD 98 million that was led by Deerfield Management Company, with participation from Aperture Venture Partners, BRM Group, Endeavour Vision, Johnson & Johnson Innovation – JJDC Inc., Pontifax, Pura Vida Investments, GHS Fund (Quark Venture LP), BioBlast, Triventures and Israel Secondary Fund.
  • Represented Augmedics in its Round C Investment Round during which the company raised about USD 35 million from several investors.

Liad Whatstein & Co. Law Office

Liad Whatstein & Co. Law Office is a full-service IP firm, regularly acting in Israel’s prominent IP disputes in the life sciences field, and providing bespoke advice to global pharmaceutical companies on complex licensing transactions and regulations. The group also has experience of representing the state of Israel in patent litigation proceedings against pharma entities, along with managing trade mark portfolios for universities and research organisations. The ‘technically excellent’ Liad Whatstein specialises in acting for clients in patent litigation and handling complex regulatory issues, and Amira Mangelus routinely handles infringement actions and large patent portfolios for major pharmaceutical players.

Practice head(s):

Liad Whatstein; Amira Mangelus


Other key lawyers:

Oren Weiner; Gershon Finesilver


Testimonials

‘They have excellent legal knowledge, and provide very detailed and insightful advice about patent status, scope, validity, and recommended actions. They are very personable and very smart, dedicated attorneys. They respond promptly, and have broad business acumen and industry knowledge of the pharmaceutical sector, not only in Israel, but outside of Israel as well. Their advice is clear and thorough, which enables me to in turn convey that advice to my company’s business leaders. They are my “go to” firm in Israel.’

‘I work with Liad Whatstein and Amira Mangelus. They are incredible attorneys, but are also personally interesting, very easy and enjoyable to work with, and highly esteemed by myself and my outside attorneys in other countries.’

‘The firm is technically adept in a broad range of life science technologies, among others because of the extensive experience they have had in most major life science litigation proceedings in Israel as well as involvement in numerous cross-border proceedings. The familiarity with cross-border litigation is helpful as there are some pain points in any coordination work and it is great that the lawyers understand the importance of their market relative to other commercial markets. The firm’s Israel court and ILPTO procedure and how to effectively cross-examine experts is also very valuable.’

‘Liad Whatstein is a technically excellent, diligent and dedicated partner who is always available. He spends time personally with experts and develops the arguments and comes up with excellent briefs. Gershon Finesilver is a stand-out associate who has excellent technical knowledge and understanding of complex scientific matters.’

Key clients

Novartis


Merck


Roche


Pfizer


The State of Israel


Sanofi


Leo Pharma


Regeneron


Purdue/MundiPharma


Lundbeck


Abbott


Bayer


Biogen


Astellas


Alkermes


UCB Pharma


Dr. Fischer Pharmaceuticals


Novo Nordisk


BMS


Alkermes


Genzyme


Takeda


Advanced Accelerators Applications (a Novartis Company)


InterMune


Immunogen Inc.


Work highlights


  • Represented Sanofi in the first-ever rehearing of a patent case by an expanded panel of Justices of the Supreme Court in a rehearing of the Supreme Court judgment in the matter of Sanofi v. Unipharm.
  • Represented Sanofi and Regeneron in highly complex proceedings against Amgen’s patent claiming anti-PCSK9 antibodies.
  • Advising major pharmaceutical companies such as Merck, Sanofi, Novartis, Pfizer, Regeneron on regulatory aspects of drug approval and data protection in Israel.

Meitar law offices

The life sciences and healthcare team Meitar Law Offices represents companies in the pharmaceutical, healthcare and technology industries in contentious and non-contentious issues. The department offers a range of services, spanning from guidance on life science regulation to product liability litigation. Boaz Mizrahi has expertise in advising clients on licensing and IP transactions, and Haim Gueta assists medical device companies with complex cross-border transactions and mergers and acquisitions. Ron Peleg is an expert in international litigation and pharmaceutical product liability matters.

Practice head(s):

Haim Gueta; Boaz Mizrahi; Ron Peleg


Other key lawyers:

Michal Weiner; Shay Reiner; Daniel Colthof


Testimonials

‘Meitar has a strong team, with a high professional level, approachable and available to discuss many legal aspects related to our business. All the issues we have raised have been treated based on their experience, including the regions we operate in.’

‘The team is highly professional and detailed oriented. When difficulties arose, the team was able to find solutions and advise us how to handle the communication.’

‘It’s the largest firm in Israel and has expertise in all practices in law.’

‘Interactions with their lawyers from the commercial and hi-tech field is warm and to the point.’

Key clients

Chemomab Therapeutics Ltd.


Bionaut Labs Ltd.


Elleos Mental Systems Ltd.


Alive Israel Healthtech Fund L.P.


Neura Inc.


Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz specialises in advising major healthcare and life sciences entities on patent diligence matters alongside general commercial issues. The group has strength representing startups and pharmaceutical multinationals in raising capital from the public, as well as handling their litigation and employment issues. Zeev Pearl has over 25 years’ experience of assisting clients with IP issues including licensing, litigation and commercial transactions, and Mark S. Cohen brings expertise in patent prosecution and drafting agreements. Yael Baratz is experienced in technology transactions and cross-border mergers.

Practice head(s):

Zeev Pearl; Mark Cohen; Yael Baratz


Other key lawyers:

Hili Rashkovan; Inbal Perlstein-Mandelbaum; Ephraim Heiliczer; Ofra Kaplan; Michal Aiash Maslansky


Testimonials

‘The team has been handling all our software/product commercial issues and contracts/transactions worldwide and has done an outstanding job. We have been working primarily with Mr. Dotan Hammer who is guiding and leading all our commercial projects and transactions. He is an excellent counsel, extremely knowledgeable and sophisticated in the software industry, and always takes the time to fully understand our business and products.’

Key clients

Bayer AG


Rambam Health Care Campus


Pfizer Inc.


Sanofi S.A.


Orgenesis Inc.


Dexcel Pharma


SAREL – Logistics Solutions & Products for Advanced Medicine Ltd.


Maccabi Health Services


Biondvax Pharmaceuticals Ltd.


Ayala Pharmaceuticals


Verliy Life Sciences


SciVac Ltd.


KAHR Medical Ltd.


Society of Public Hospitals for the Public


Estar Medical


340Basics (Empowered by Nuvem)


Hillel Yaffe Medical Center


Shamir Medical Center (Assaf Harofeh)


Poriya Medical Center


Marpai Inc. (NASDAQ: MRAI)


Amoon Fund


Nobio Ltd


Work highlights


  • Representing Bayer AG, Sanofi, Pfizer, Medtronic, Illumina, CSL Behring and other global life science companies in securing their IP rights in Israel as well as in regulatory, corporate and tax matters.
  • Representing Maccabi, a leading HMO, Rambam, a leading Haifa based university hospital, SAREL, the procurement arm for hospitals and medical institutions and other leading Israeli health service organizations in a raft of legal services, such as advising on all aspects of corporate, licensing, labor law and litigation.
  • Represented Marpai in a $60M acquisition of an AXA company, mpharma in a $35M round of financing, KAHR in a $56M round of finance, Orgenesis in the acquisiton of Tamir medical, and many others life science and health services growth companies in financing, licensing, clinical trials and other transactions.

Shibolet & Co.

Shibolet & Co. provides a comprehensive service to public and private hi-tech and start-up companies working in the life sciences industry. The team combines expertise in IP and regulatory law with strength in commercial transactions and litigation. Ofer Ben-Yehuda regularly advises on cross-border transactions, and Einat Weidberg has 20 years of experience of representing foreign and Israeli clients in M&A. Tal Karplus focuses on complex licensing and technology transfer transactions.

Practice head(s):

Ofer Ben-Yehuda; Einat Weidberg


Other key lawyers:

Tal Karplus; Amos Bentzur; Iris Pappo; Daniel Kariv; Chezi Yehezkeli; Yoav Manor; Gal Shnaiberg


Key clients

OBCTCD 24 Ltd.


Pluristem Ltd.


Nobio Ltd


VUZE medical


CartiHeal (2009) Ltd.


The Trendlines Group Ltd.


Elron Electronic Industries Ltd.


Alon Medtech Ventures Ltd.


BeyeOnics Surgical Ltd.


OrthoSpin Ltd.


NovoCure (Israel) Ltd.


Technion Research and Development Foundation Ltd. and Technion Investment Opportunities Fund


Ancora Medical


ApiFix Ltd.


RDD Pharma Ltd.


Compugen Ltd.


Work highlights


  • Advised Cartiheal Ltd. in connection with the put/call acquisition transaction with Bioventus LLC, the definitive agreement for which was signed on July 15, 2020.
  • Represented the medical technology company, BeyeOnics, in the spin-off of BeyeOnics Surgical’s ophthalmic division into a separate entity (i.e., BeyeOnics Vision).
  • Negotiating a deal comprised of an acquisition of the entire IP of the target, followed by the acquisition of 100% of the target’s equity, including drafting all legal paperwork, presenting and explaining the deal to the target’s board of directors and shareholders, and obtaining applicable regulatory consents.